Jim Simons Amarin Corp Plcuk Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.12 - $1.49 $25,536 - $33,972	-22,800 Reduced 29.73%	53,900 $64,000
Q1 2023 May 12, 2023	BUY	$1.19 - $2.19 $91,273 - $167,973	76,700 New	76,700 $115,000
Q3 2021 Nov 12, 2021	SELL	$3.94 - $5.84 $5.57 Million - $8.25 Million	-1,413,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$4.26 - $6.5 $2.21 Million - $3.38 Million	-519,600 Reduced 26.89%	1,413,000 $6.19 Million
Q1 2021 May 13, 2021	SELL	$5.03 - $8.8 $4.94 Million - $8.64 Million	-981,918 Reduced 33.69%	1,932,600 $12 Million
Q4 2020 Feb 10, 2021	BUY	$4.04 - $5.31 $1.43 Million - $1.88 Million	353,538 Added 13.8%	2,914,518 $14.3 Million
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $4.56 Million - $9.72 Million	-1,252,281 Reduced 32.84%	2,560,980 $10.8 Million
Q2 2020 Aug 13, 2020	BUY	$4.78 - $8.26 $6.93 Million - $12 Million	1,449,260 Added 61.31%	3,813,261 $26.4 Million
Q1 2020 May 14, 2020	BUY	$4.0 - $21.53 $9.46 Million - $50.9 Million	2,364,001 New	2,364,001 $9.46 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.